Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ling Lv
Institutions:
Third Affiliated Hospital of Guangzhou Medical University,
First Hospital of China Medical University,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
Third Affiliated Hospital of Guangzhou Medical University,
First Hospital of China Medical University,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
ORCID:
0000-0003-0972-4745
Observed ORCID:
0000-0003-0972-4745
OpenAlex ID:
A5005501738
Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy
2024
·
Zhiqiang Mo
, Ling Lv
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
Comparison of the Efficacy and Safety of Single-Session OK-432 and Multiple-Session 99% Ethanol Sclerotherapy for Symptomatic Simple Hepatic Cysts
2022
·
Zhiqiang Mo
, Fangfang Yang
, et al.
·
Frontiers in Medicine
·
7
PDF
EGFR mutations in patients with lung adenocarcinoma and malignant pleural effusion: a propensity score-matched analysis of a single-center database
2024
·
Qiwei Yang
, Ziyi Wang
, et al.
·
Translational Lung Cancer Research
·
4
Serum Neutrophil/Lymphocyte Ratio as a Potential Predictor of Treatment Response for PD-1 Blockade Therapy in Patients with Advanced Hepatocellular Carcinoma
2022
·
Zhiqiang Mo
, Qicong Mai
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
4
Citation count:
19
H-index:
3
I10-index:
Year
Topic
Type